Companies / Dbv Technologies S.A.

Dbv Technologies S.A.

Nasdaq: DBVTCIK 1613780CHATILLONdbv-technologies.com

Financials · FY2025

Revenue$5.64M
Net income$-146.95M
Total debt$510.0K
Cash$174.90M
Diluted EPS$-1.05
Shares outstanding296.1M

Ownership

296.1M shares outstanding · as of Jul 16, 2026
1.1%10%+ / strategic
Ownership
10%+ / strategic1.12%3,309,055
Institutions4.65%13,778,624
Public float94.23%278,973,818

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
667, L.P.FormerDirector
Baker FelixFormerDirector
Baker JulianFormerDirector
Mohideen PharisChief Medical Officer

Institutional holders 59

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 29, 2026Mohideen Pharis
Executive
SellOrdinary Shares$2.6K-534
-0.37%
144,995
0.05% of shares
low
Jan 12, 2026Baker Bros. Advisors LP
Director
ExerciseSecond Pre-Funded Warrant+25.0M
25,005,240
8.45% of shares
low
Jan 12, 2026Baker Bros. Advisors LP
Director
ExerciseSecond Pre-Funded Warrant+2.3M
2,299,656
0.78% of shares
low
Jan 12, 2026Baker Bros. Advisors LP
Director
ExerciseBS Warrant-25.0M
-100.00%
0
0.00% of shares
low
Jan 12, 2026Baker Bros. Advisors LP
Director
ExerciseBS Warrant-2.3M
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Janus Henderson Group PLCPassive13G/A
Citadel Advisors LLCPassive13G/A
Artisan Partners Asset Management Inc.Passive13G3,309,055
Venrock Healthcare Capital Partners II, L.P.Passive13G/A
Vivo Opportunity Fund Holdings, L.P.Passive13G/A
Invus, L.P.Passive13G/A
MPM BioImpact LLCPassive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DBVTADREquity23306J309BBG0076D3T39